Biological treatment of rapid-cycling bipolar disorder

Pharmacopsychiatry

Volumn 29, Issue 5, 1996, Pages 167-175

  Krüger, Stephanie ^a,c   Braunig P ^a   Young, L T ^b,c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BENZODIAZEPINE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CLOZAPINE; ESTROGEN; LEVOTHYROXINE; LITHIUM; MAGNESIUM; NEUROLEPTIC AGENT; NIMODIPINE; VALPROIC ACID;

BIPOLAR DEPRESSION; ELECTROCONVULSIVE THERAPY; HUMAN; PRIORITY JOURNAL; REVIEW; SLEEP DEPRIVATION;

EID: 0029838890     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979566     Document Type: Review

References (129)

1. Abou-Saleh, M. T.: Who responds to prophylactic lithium? J. Aff. Disord. 10 (1986) 115-125
2. Ahlfors, U. G., P. C. Baastrup, S. J. Denker, C. Elgen, M. Lingjaerde, V. Pedersen, M. Schou, O. Aaskoven: Flupenthixol decanoat in recurrent manic-depressive illness. A comparison with lithium. Acta Psychiatr. Scand. 64 (1981) 226-237
3. Alarcon, R. D.: Rapid cycling affective disorders. A clinical review. Compr. Psychiatry 26 (1985) 522-540
4. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, Fourth Edition. Washington, DC: American Psychiatric Association, 1994.
5. Angst, J.: Switch from depression to mania. A record study over the decades 1920-1982. Psychopathology 18 (1985) 140-154
6. Bauer, M. S., P. C. Whybrow: Rapid cycling affective disorder. Treatment of refractory rapid cycling with high dose levothyroxine: A preliminary study. Arch. Gen. Psychiatry 47 (1990) 435-440
7. Bauer, M. S., J. R. Calabrese, D. L. Dunner: Multi-site data reanalysis: Validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am. J. Psychiatry 151 (1994) 506-515
8. Berman, E., E. A. Wolpert: Intractable manic-depressive illness with rapid cycling in an 18-year-old woman successfully treated with ECT. J. Nerv. Ment. Dis. 4 (1987) 236-239
9. Bräunig, P.: Hochfrequenter Phasenwechsel ("rapid cycling") als Komplikation bei bipolaren affektiven Psychosen. Zbl. Neurol. Psychiat. 251 (1989) 835-847
10. Bräunig, P.: Switch processes and rapid cycling in bipolar affective disorders, cycloid psychoses and non-systematic schizophrenia. Psychopathology 23 (1990) 291-302
11. Bräunig, P.: Seit 15 Jahren ununterbrochenes Alternieren bipolarer Zyklen - über eine primär chronische Zyklothymie. Krankenhauspsychiatrie 2 (1991) 136-138
12. Bräunig, P., S. Krüger, M. Lasar: Rapid cycling bei episodischen Psychosen. In: Peters, U. H., A. Schifferdecker, A. Krahl (Hrsg.): 150 Jahre Psychiatrie. Eine vielgestaltige Psychiatrie für die Welt von morgen. Martini Verlag, Köln (1995) 23-26
13. Brown, G. M., G. H. Stone, M. P. Rathbone: Primidone and rapid cycling (letter). Lancet 342, 8876 (1993) 925
14. Bunney, W. E., E. L. Hartmann: Study of a patient with 48-hour manic-depressive cycles. Arch. Gen. Psychiatry 12 (1965) 611-618.
15. Bunney, W. E. Jr: Psychopharmacology of the switch process in affective illness. In: Lipton, M. A., A. DiMascio, K. F. Kellem (eds.): Psychopharmacology: a generation of progress. Raven Press, New York (1978) 134-144
16. Calabrese, J. R., C. Delucchi: Phenomenology of rapid cycling bipolar manic-depression and its treatment with valproate. J. Clin. Psychiatry 50 (1989) 30-34
17. Calabrese, J. R., C. Delucchi: Spectrum of efficacy of valproate in 55 patients with rapid cycling bipolar disorder. Am. J. Psychiatry 147 (1990) 431-434
18. Calabrese, J. R., H. Y. Meltzer, P. Markowitz: Clozapine prophylaxis in rapid cycling bipolar disorder. J. Clin. Psychopharmacol. 11 (1991) 396-397
19. Calabrese, J. R., D. J. Rapport, S. E. Kimmel, B. Reece, M. Woyshville: Rapid cycling bipolar disorder and its treatment with valproate. Can. J. Psychiatry (Suppl.) 38 (1993) 57-61
20. Calabrese, J. R., M. J. Woyshville: A medication algorithm for treatment of bipolar rapid cycling? J. Clin. Psychiatry 56 (Suppl.) 3 (1995) 11-18
21. Carman, J. S., J. S. Wyatt: Calcium: Pacesetting the periodic psychoses. Am. J. Psychiatry 136 (1979) 1035-1039
22. Cho, J. T., S. Bone, D. L. Donner: The effect of lithium treatment on thyroid function in patients with primary affective disorder. Psychiatry Res. 25 (1988) 117-121
23. Chouinard, G., L. Beauclair, R. Geiser: A pilot study of magnesium aspartate hydrochloride (Magnesiocard) as a mood stabilizer for rapid cycling bipolar affective disorder patients. Progr. Neuro-Psychopharmacol. Biol. Psychiatry 14 (1990) 171-180
24. Coryell, W., J. Endicott, M. Keller: Rapid cycling affective disorders: Demographics, diagnosis, family history and course. Arch. Gen. Psychiatry 49 (1992) 126-131
25. Cowdry, R. W., T. A. Wehr, A. P. Zis, F. W. Goodwin: Thyroid abnormalities associated with rapid cycling bipolar illness. Arch. Gen. Psychiatry 40 (1983) 414-420
26. Davis, J. M.: Overview: Maintenance therapy in psychiatry II: affective disorders. Am. J. Psychiatry 133 (1976) 1-13
27. Del Zompo, M., C. Burrai, M. P. Piccardi: Prophylactic efficacy of carbamazepine in lithium-resistant affective disorders. In: Corsini, G. U. (ed.): Current trends in lithium and rubidium therapy. Lancaster PA: MTP Press: (1983) 325-330
28. de Montigny, C., F. Grunberg, A. Mayer: Lithium induces rapid relief of depression in tricyclic antidepressant non-responders. Br. J. Psychiatry (1981) 252-256
29. Dilsaver, S. C., J. F. Greden: Antidepressants withdrawal-induced activation (hypomania and mania): mechanism and theoretical significance. Brain Res. 7 (1984) 29-48
30. Dose, M., H. M. Emrich, C. Cording-Tommel, D. von Zerssen: Use of calcium antagonists in mania. Psychoneuroendocrinology 11 (1986) 241-243
31. Dostal, T.: Double-blind study of the therapeutic and prophylactic effects of lithium salts in psychiatry. Candidate dissertation: Research Institute of Psychiatry, Prague (1977)
32. Dunner, D. L., R. R. Fieve: Clinical factors in lithium prophylactic failure. Arch. Gen. Psychiatry 30 (1974) 229-233
33. Dwight, M. M., P. E. Keck, S. P. Stanta, S. M. Strakowski, S. L. McElroy: Antidepressant activity and mania associated with risperidone. Lancet 344, 8921 (1994) 554-555
34. Elphick, M.: An open trial of carbamazepine in treatment resistant bipolar and schizoaffective psychotics. Br. J. Psychiatry 147 (1985) 198-200
35. Emrich, H. M., D. von Zerssen, W. Kissling, H. J. Möller, A. Windorfer: Effect of sodium valproate on mania: the GABA-hypothesis of affective disorders. Arch. Psychiatr. Nervenkr. 229 (1980) 1-16
36. Emrich, H. M., M. Dose, D. von Zerssen: The use of sodium valproate and oxacarbazepine in patients with affective disorders. J. Aff. Disord. 8 (1985) 243-250
37. Fawcett, J., A. Scheftner, D. Clark: Clinical predictors of suicide in patients with major affective disorders: a controlled prospective study. Am. J. Psychiatry 144 (1987) 35-40
38. Fieve, R. R., E. D. Peselow: Lithium: Clinical applications. In: Burrows, G. D., T. R. Nomal, B. Cavies (eds): Antidepressants. Elsevier, Amsterdam (1983) 277-321
39. Frankenburg, F. R., M. Tohen, B. M. Cohen: Long-term response to carbamazepine: a retrospective study. J. Clin. Psychopharmacology 8 (1988) 130-133
40. Gann, H., D. Riemann, F. Hohagen, L. G. Strauss, H. Dressing, W. E. Müller, M. Berger: 48-hour rapid cycling: results of psychopathometric, polysomnographic, PET imaging and neuro-endocrine longitudinal investigations in a single case. J. Aff. Disord. 28 (1993) 133-140
41. Goldberg, A.: Alprazolam versus imipramine in depressed outpatients with neurovegetative signs. J. Affect. Disord. 11 (1986) 139-145
42. Goldstein, J. A.: Danazol and the rapid cycling patient. J. Clin. Psychiatry 47 (1986) 3
43. Goodnick, P. J., R. R. Fieve, A. Schlegel, N. Baxter: Predictors of interepisode symptoms of relapse in affective disorder patients treated with lithium carbonate. Am. J. Psychiatry 144 (1987) 367-369
44. Goodwin, F. K., A. P. Zis: Lithium in the treatment of mania: comparisons with neuroleptics. Arch. Gen. Psychiatry 36 (1979) 840-844
45. Goodwin, F. K., M. Ebert: Lithium in mania: clinical trials and controlled studies. In: Gershon, S., B. Shopsin (ed.): Lithium: Its role in psychiatric research and treatment. Plenum Press, New York (1987)
46. Goodwin, F. K., K. R. Jamison: Manic-depressive illness. New York, Oxford, University Press (1990) 655-656
47. Greil, W., R. Krüger, G. Robnagel: Prophylactic therapy of affective disorders with carbamazepine: an open clinical trial. In: Emrich, H. M., T. Okuma, A. A. Müller (ed.): Anticonvulsants in affective disorders. Amsterdam, The Netherlands. Excerpta Medica (1984) 153-159
48. Grof, E., M. Haag, P. Grof, H. Haag: Lithium response and the sequence of episode polarities: Preliminary report on a Hamilton sample. Progr. Neuropsychopharmacol. Biol. Psychiatry 11 (1987) 199-203
49. Haag, H., A. Heidorn, M. Haag: Sequence of affective polarity and lithium response: preliminary report on the Munich sample. Progr. Neuropsychopharmacol. Biol. Psychiatry 11 (1987) 205-208
50. Hanna, S. M., F. A. Jenner, I. B. Pearson, G. A. Sampson, E. A. Thompson: The therapeutic effect of lithium carbonate in a patient with 48-hour rapid cycling. Brit. J. Psychiatry 121 (1972) 271-280
51. Hanus, H., M. Zapletalek: The prophylactic lithium treatment in affective disorders and the possibilities of the outcome prediction. Ceskoslovenska Psychiatrie 80 (1984) 97-100
52. Harrow, M., J. F. Goldberg, L. S. Grossmann, H. Y. Meltzer: Outcome in manic disorders: a naturalistic follow-up study. Arch. Gen. Psychiatry 47 (1990) 665-667
53. Hayes, S. G.: Barbiturate anticonvulsants in refractory affective disorders. Ann. Clin. Psychiatry 5 (1983) 35-44
54. Hayes, S. G.: Acetazolamide in primary psychiatric disorders. Neuropsychopharmacol. (Suppl.) 9 (1983) 131
55. Hayes, S. G.: Long-term use of valproic acid in primary psychiatric disorders. J. Clin. Psychiatry 50 (Suppl.) 3 (1989) 35-39
56. Haykal, R. F., H. S. Akiskal: Bupropion as a promising approach to rapid cycling bipolar II patients. J. Clin. Psychiatry 51 (1990) 450-455
57. Henninger, G. R., D. S. Charney, D. E. Sternberg: Lithium carbonate augmentation of antidepressant treatment. Arch. Gen. Psychiatry 140 (1983) 1335-1342
58. Herridge, P. L., H. G. Pope Jr: Treatment of bulimia and rapid cycling bipolar disorder with sodium valproate: a case report. J. Clin. Psychopharmacol. 5 (1985) 229-330
59. Himmelhoch, J. M.: Mixed states, manic depressive illness and the nature of mood disorders. Psychiatr. Clin. North America 2 (1979) 449-459
60. Hoschl, C., J. Kozeny: Verapamil in affective disorders: A controlled, double-blind study. Biol. Psychiatry 25 (1989) 128-140
61. Inoue, K., S. Arima, K. Tanaka: A lithium and carbamazepine combination in the treatment of bipolar disorder: a preliminary report. Folia Psychiatr. Neurol. Japonica 35 (1981) 465-476
62. Itoh, K., M. Ishigane: On the clinical effectiveness of lithium carbonate for manic depressive reactions: therapeutic and prophylactic effects. Shiniako-to-Rinsho 22 (1973) 1001-1015
63. Jenner, F. A., L. R. Gjessing, J. R. Cox: A manic-depressive psychotic with a persistent forty-eight hour cycle. Br. J. Psychiatry 113 (1967) 895-910
64. Joffe, R. T., C. Kutcher, C. McDonald: Thyroid function and bipolar affective disorder. Psychiatry Res. 25 (1988) 117-121
65. Joffe, R. T., A. J. Levitt: The thyroid axis and psychiatric illness. American Psychiatric Press (1993) 182-184, 204-206, 234
66. Jones, B. D., S. Steinberg, G. Chouinard: Fast-cycling bipolar disorder induced by withdrawal from long-term treatment with a tricyclic antidepressant. Am. J. Psychiatry 141 (1984) 108-109
67. Joyce, P. R.: Carbamazepine in rapid cycling bipolar affective disorder. Int. Clin. Psychopharmacol. 3 (1988) 123-129
68. Kanter, C. I., B. I. Yerevanian, J. R. Ciccone: Case report of a possible interaction between neuroleptics and carbamazepine. Am. J. Psychiatry 141 (1984) 1101-1102
69. Keck, P. E. Jr, S. L. McElroy, A. Vuckowic, L. M. Friedman: Combined valproate and carbamazepine treatment of bipolar disorder. J. Neuropsychiatry Clin. Neurosci. 4 (1992) 319-322
70. Ketter, T. A., P. J. Pazzaglia, R. M. Post: Synergy of carbamazepine and valproic acid in affective illness: a case report and review of the literature. J. Clin. Psychopharmacol. 12 (1992) 276-281
71. Kishimoto, A., C. Ogura, A. Hazama. K. Inuoe: Long-term prophylactic effects of carbamazepine in affective disorder. Br. J. Psychiatry 143 (1983) 327-331
72. Kishimoto, A., C. Ogura, A. Hazama: Long-term prophylactic effects of carbamazepine in affective disorder. Br. Psychiatry 143 (1986) 327-331
73. Kishimoto, A., F. Omura, K. Inoue, H. Hazama: A comparative study of carbamazepine and lithium for prophylaxis of bipolar affective disorder. Yonago Acta Medica 29 (1987) 76-90
74. Klosiewicz, L.: The prophylactic influence of valproic acid amide in affective illness. Psychiatr. Pol. 19 (1985) 23-29
75. Kramlinger, K. G., R. M. Post: "Ultra-rapid cycling bipolar affective disorders". Paper presented at the annual meeting of the Psychiatric Research Society, Park City, UT (1988) 100-112
76. Kukopulos, A., D. Reginalds, P. Laddomada, G. Floris, G. Serra, L. Tondo: Course of the manic-depressive cycle and changes caused by treatment. Pharmacopsychiatr. Neuropharmacol. 13 (1980) 156-167
77. Kukopulos, A., B. Caliari, A. Tundo, G. Minnai, G. Floris, D. Reginaldi, L. Tondo: Rapid cyclers, temperament and antidepressants. Compr. Psychiatry 24 (1983) 249-258
78. Kwamie, Y., E. Persad, H. Stancer: The use of carbamazepine as an adjunctive medication in the treatment of affective disorders: A clinical report. Can. J. Psychiatry 29 (1984) 605-608
79. Laird, L. K., E. P. Knox: The use of carbamazepine and lithium in controling a case of chronic rapid cycling. Pharmacotherapy 7 (1986) 130-132
80. Lange, E., W. Heisig, W. Felber, L. König: Ergebnisse der Rezidivprophylaxe affektiver Psychosen. Psychiat. Neurol. Med. Psychol. 41 (1989) 476-484
81. Levy, J. M., R. A. Remick: Clinical aspects and treatment of rapid cycling mood disorders. Can. J. Psychiatry 31 (1986) 4436-4441
82. Lovett, L., S. E. Watkins, D. M. Shaw: The use of alternative drug therapy in nine patients with recurrent affective disorder resistant to conventional prophylaxis. Biol. Psychiatry 21 (1986) 1344-1347
83. Maj, M., L. Magliano, R. Pirozzi: Validity of rapid cycling as a course specifier for bipolar disorder. Am. J. Psychiatry 151 (1994) 1015-1019
84. Manna, V.: Therapeutic effects of the treatment with lithium salts and/or calcium antagonists in patients with rapid polar inversion. Minerva Medica 82 (1991) 757-763
85. McElroy, S. L., P. E. Keck Jr, H. G. Pope Jr: Valproate in the treatment of rapid cycling bipolar disorder. J. Clin. Psychopharmacol. 8 (1988) 275-279
86. McElroy, S. L., P. E. Keck, H. G. Pope, J. L. Hudson: Valproate in the treatment of bipolar disorder: Literature review and clinical guidelines. J. Clin. Psychopharmacol. (Suppl.) 12 (1992) 42-58
87. Menninger-Lerchenthal, E.: Periodizität in der Psychopathologie. Maudrich, Wien, Bonn, Bern (1960)
88. Meyer, R. E., M. N. Hesselbrock: Psychopathology and addictive disorders revisited. In: Mirin, S. M. (ed.): Substance abuse and Psychopathology. Washington: American Psychiatric Press (1984) 1-18
89. Misra, P. C., B. H. Burns: "Lithium non-responders" in a lithium clinic. Acta Psychiatr. Scand. 55 (1977) 32-40
90. Nierenberg, A. A. J. D. Amsterdam: Treatment-resistant depression: Definition and treatment approaches. J. Clin. Psychiatry (Suppl.) 51 (1990) 39-47
91. Nolen, W. A. S.: Carbamazepine, a possible adjunct or alternative to lithium in bipolar disorder. Acta Psychiatr. Scand. 67 (1983) 218-225
92. Okuma, T., A. Kishimoto, K. Inoue: Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic-depressive psychosis: a preliminary report. Folia Psychiatr. Neurol. Japonica 27 (1973) 283-297
93. Okuma, T.: Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology 27 (1993) 138-145
94. Oppenheim, G.: Drug-induced rapid cycling. Possible outcomes and management. Am. J. Psychiatry 139 (1982) 939-941
95. Page, C., S. Benaim, F. Lappin: A long-term follow-up study of patients treated with prophylactic lithium carbonate. Br. J. Psychiatry 150 (1987) 175-179
96. Papadimitriou, G. N., G. N. Christodoulou, G. Trikkes: Sleep deprivation prophylaxis in recurrent affective disorders. Bibliotheca Psychiatrica 160 (1981) 56-61
97. Papadimitriou, G. N., G. N. Cnristodoulou, K. Katsouyianni, C. N. Stefanis: Therapy and prevention of affective illness by total sleep deprivation. J. Aff. Disord. 27 (1993) 107-116
98. Paschalis, C., A. Pavlou, A. Papadimitriou: A stepped 48-hours manic-depressive cycle. Br. J. Psychiatry 137 (1980) 332-336
99. Peet, M.: Induction of mania with selected serotonin-reuptake inhibitors and tricyclic antidepressants. Br. J. Psychiatry 164 (1994) 549-550
100. Post, R. M., K. M. Squillace: Prophylactic efficacy of carbamazepine in manic-depressive illness. Am. J. Psychiatry 140 (1983) 1602-1604
101. Post, R. M., W. Berettini, T. W. Uhde: Selective response to the anticonvulsant carbamazepine in manic-depressive illness: A case study. J. Clin. Psychopharmacol. 4 (1984) 178-185
102. Post, R. M., T. W. Uhde, P. P. Roy-Burne: Correlates of antimanic response to carbamazepine. Psychiatry Res. 21 (1987) 71-83
103. Post, R. M., K. G. Kramlinger, L. L. Altshuler: Treatment of rapid cycling bipolar illness. Psychopharmacol. Bull. 26 (1990a) 37-47
104. Post, R. M., G. S. Leverich, A. S. Rosoff: Carbamazepine prophylaxis in refractory affective disorders: A focus on long-term follow-up. J. Clin. Psychopharmacol. 10 (1990b) 318-327
105. Prien, R. F.: Five-center study clarifies use of lithium and imipramin for recurrent affective disorders. Hosp. Community Psychiatry 35 (1984) 1097-1098
106. Prien, R. F., A. J. Gelenberg: Alternatives to lithium for preventive treatment of bipolar disorder. Am. J. Psychiatry 146 (1989) 840-848
107. Puzynski, S., L. Klosiewicz: Valproic acid amide in the treatment of affective and schizoaffective disorders. J. Aff. Disord. 6 (1984) 115-121
108. Reginaldi, D., L. Tondo, B. Caliari: The role of antidepressants in rapid cyclicity. In: Costa, E., G. Racagni (ed.): Typical and atypical antidepressants: clinical practices. Raven Press, New York (1982)
109. Roy-Burne, P., R. H. Cerner, E. H. Liston, A. G. Robertson: ECT for acute mania: A forgotten treatment modality? J. Psychiatr. Treatm. Eval. 3 (1981) 83-86
110. Roy-Burne, P., R. T. Joffe, T. W. Uhde: Approaches to the evaluation and treatment of rapid cycling affective illness. Br. J. Psychiatry 145 (1984a) 543-550
111. Roy-Burne, P., T. W. Uhde, R. M. Post: Antidepressant effect of one night's sleep deprivation: clinical and theoretical implications. In: Post, R. M. and J. C. Ballenger (eds.): Neurobiology of Mood Disorder. Williams and Wilkins, Baltimore (1984b)
112. Sachs, C. S.: Adjuncts and alternatives to lithium therapy for bipolar affective disorder. J Clin Psychiatry (Suppl.) 50 (1989) 31-39
113. Schou, M.: Prophylactic lithium maintenance treatment in recurrent endogenous affective disorders. In: Gershon, S., B. Shopsin (eds.): Lithium: Its role in psychiatric research and treatment. Plenum Publishing Corporation N.Y. (1973) 269-295
114. Sharma, V., E. Persad, D. Mazmanian, K. Karunaratne: Treatment of rapid cycling bipolar disorder with combination therapy of valproate and lithium. Can. J. Psychiatry 38 (1993) 137-139
115. Shukla, S., B. L. Cook, M. G. Miller: Lithium-carbamazepine versus lithium-neuroleptics in bipolar illness. J. Affect. Disord. 147 (1985) 219-222
116. Small, J. G., M. H. Klapper, V. Milstein: Carbamazepine compared to lithium in the treatment of mania. Arch. Gen. Psychiatry 48 (1991) 915-921
117. Stancer, H., E. Persad: Treatment of intractable rapid cycling manic-depressive disorder with levothyroxine. Arch. Gen. Psychiatry 39 (1982) 311-312
118. Stuppaeck, C., C. Barnas, C. Miller: Carbamazepine in the treatment of mood disorders. J. Clin. Psychopharmacol. 10 (1990) 39-42
119. Stromgen, L. S., S. Boller: Carbamazepine in treatment and prophylaxis of manic-depressive disorder. Psychiatric Developments 4 (1985) 349-367
120. Tondo, L., P. Laddomada, G. Serra: Rapid cyclers and antidepressants. Int. Pharmacopsychiat 16 (1981) 119-123
121. van Scheyen, J. C., D. P. van Kammen: Clomipramine-induced mania in unipolar depression. Arch. Gen. Psychiatry 36 (1979) 560-565
122. Waters, B. G. H., Y. D. Lapierre: Therapeutic use of the tricyclic-induced switch in bipolar manic-depression. Am. J. Psychiatry 139 (1982) 245-246
123. Wehr, T. A., F. K. Goodwin: Rapid cycling between mania and depression caused by maintenance tricyclics. Psychopharmacol. Bull. 15 (1979a) 17-19
124. Wehr, T. A., F. K. Goodwin, A. Wirz-Justice: 48-hours sleep-wake cycles in manic-depressive illness. Arch. Gen. Psychiatry 39 (1982) 559-568
125. Wehr, T. A., F. K. Goodwin: Can antidepressant cause mania and worsen the course of affective illness? Am. J. Psychiatry 144 (1988a) 1403-1411
126. Wehr, T. A., D. A. Sack, N. E. Rosenthal: RCAD: Contributing factors and treatment responses in 51 patients. Am. J. Psychiatry 145 (1988b) 179-184
127. Wolpert, E. A, F. J. Goldberg, M. Harrow: Rapid cycling in unipolar and bipolar affective disorders. Am. J. Psychiatry 147 (1990) 725-728
128. Wu, J. C., W. E. Bunney: The biological basis of an antidepressant response to sleep deprivation and relapse: Review and hypothesis. Am. J. Psychiatry 147 (1990) 14-21
129. Zerssen, von, D., R. Lund, M. Doerr: 48-hour cycles of depression and their biological concomitants with and without "Zeitgebers". A case report. In: Saletu, B., P. Berner, L. Hollister (eds.): Neuro-Psychopharmacology. Pergamon Press, Oxford (1987) 233-245